Development and validation of liquid chromatography–tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma-Reference-Cited by-同舟云学术

Development and validation of liquid chromatography–tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma

Published:2007-07 Issue:1-2 Volume:854 Page:143-151
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Cui Shuangjin,Feng Fang,Ma Ming,Liu Han,Chen Yun

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference20 articles.

1. Fosinopril, a Phosphinic Acid Inhibitor of Angiotensin I Converting Enzyme: In Vitro and Preclinical In Vivo Pharmacology

2. The Effect of Captopril on Renal Hemodynamics in Hypertensive Patients

3. Disposition of fosinopril sodium in healthy subjects.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A sensitive and efficient LC–MS/MS method for the bioanalysis of fosinopril diacid from human plasma and its application for a bioequivalence study in humans;Biomedical Chromatography;2021-02-02

2. Simultaneous ultraperformance liquid chromatography/tandem mass spectrometry determination of four antihypertensive drugs in human plasma using hydrophilic-lipophilic balanced reversed-phase sorbents sample preparation protocol;Biomedical Chromatography;2018-10-11

3. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors;The Pharmacogenomics Journal;2015-06-16

4. Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug;Journal of Chromatography B;2015-05

5. Identification of metabolites of fosinopril produced by human and rat liver microsomes with liquid chromatography–mass spectrometry;European Journal of Pharmaceutical Sciences;2014-03